Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
FDA Inspection
•Livzon Group (Ningxia) Pharmaceutical Co., Ltd.•October 19, 2018

Livzon Group (Ningxia) Pharmaceutical Co., Ltd. – FDA Inspection, Oct 19, 2018

Record Details

This FDA Inspection record concerns Livzon Group (Ningxia) Pharmaceutical Co., Ltd., with an inspection on October 19, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
Inspection Date
October 19, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Joel D. Hustedt (FDA Associated Person)
View Company Profile

ID · a82b46fe-c65c-416b-a72d-567fb166f2f3

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1070291
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

Other FDA inspections of Livzon Group (Ningxia) Pharmaceutical Co., Ltd.

3
DateClassificationOfficeProject area
September 5, 2025NAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
December 6, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 13, 2017VAICenter for Veterinary MedicinePre-Approval Eval. of Animal Drugs and Food Additives
Other documents for Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
  • FDA Inspection 1286526 - 2025-09-05
  • FDA Inspection 1115730 - 2019-12-06
  • FDA Inspection 998978 - 2017-01-13

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.